Dr. Maki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
BAIC-14
300 E 66th St
New York, NY 10065Phone+1 646-888-5059Fax+1 929-321-7323- Is this information wrong?
Summary
- I am a medical oncologist with principal clinical specialization in sarcomas of soft tissue and bone, such as osteogenic sarcoma, Ewing sarcoma, GIST, leiomyosarcoma, angiosarcoma, synovial sarcoma and malignant peripheral nerve sheath tumor and other connective tissue tumors such as desmoid tumors and giant cell tumors. I participate in both the experimental therapeutic (phase 1) and sarcoma research programs, and also take part in sarcoma translational research. Offers to collaborate are always welcome.
Please see asco.org to obtain my email address. I do not check this site often. Please also see https://orcid.org/0000-0002-9853-2528 on ORCID for publications.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1995 - 1998- Brigham and Women's HospitalResidency, Internal Medicine, 1992 - 1995
Weill Cornell MedicineClass of 1992
Certifications & Licensure
CT State Medical License 2023 - 2025
NY State Medical License 1999 - 2025
NJ State Medical License 2020 - 2025
FL State Medical License 2020 - 2024
PA State Medical License 2019 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Worst Doctors Journal of Irreproducible Results, 2018
- FASCO (Fellow of the American Society of Clinical Oncology) American Society of Clinical Oncology, 2018
- Fellow (FACP) American College of Physicians
Publications & Presentations
PubMed
- Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma.Josephine K Dermawan, Sarah Chiang, Samuel Singer, Bhumika Jadeja, Martee L Hensley, William D Tap, Sujana Movva, Robert G Maki, Cristina R Antonescu> ;Clinical Cancer Research. 2024 Mar 15
- Trials and Tribulations in Rare Cancer Clinical Research.Maki, R.> ;Journal of Clinical Oncology. 2024 Mar 10
- The Weighted Toxicity Score: Confirmation of a Simple Metric to Communicate Toxicity in Randomized Trials of Systemic Cancer Therapy.Jacob Jordan, Maki, R. G., Robert G Maki> ;The Oncologist. 2024 Jan 5
- Join now to see all
Journal Articles
- TERT Promoter Mutations in Solitary Fibrous TumorRobert Maki, MD, Histopathology
Press Mentions
What Is Cardiac Angiosarcoma?November 29th, 2021- TRACON Pharmaceuticals to Host Key Opinion Leader Webinar on Envafolimab for the Treatment of SarcomaJuly 13th, 2020
Israeli Scientists Say They'll Have Cure for Cancer Within a Year. Here's Why That's Highly UnlikelyJanuary 31st, 2019- Join now to see all
Professional Memberships
- Member
- Member
- Member
- GEIS: Spanish Sarcoma GroupMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
